Sanofi
Sanofi, a global healthcare leader headquartered in France, is renowned for its commitment to improving health and well-being. Founded in 2004 through the merger of Sanofi-Synthélabo and Aventis, the company has established a strong presence in key operational regions, including Europe, North America, and Asia. Operating within the pharmaceutical and biotechnology industry, Sanofi focuses on several main business areas, including prescription medicines, vaccines, and consumer healthcare products. Its core offerings, such as innovative treatments for diabetes, rare diseases, and vaccines, are distinguished by their scientific rigor and patient-centric approach. With a robust market position, Sanofi has achieved notable milestones, including advancements in immunology and oncology, solidifying its reputation as a trusted name in global health solutions.
DitchCarbon Score
How does Sanofi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sanofi's score of 99 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sanofi's reported carbon emissions
In 2023, Sanofi reported total greenhouse gas emissions of approximately 332,470,000 kg CO2e for Scope 1, 332,149,000 kg CO2e for Scope 2, and 4,025,012,000 kg CO2e for Scope 3 emissions. This reflects their ongoing commitment to reducing carbon emissions across their operations. Sanofi has set ambitious targets to achieve significant reductions in greenhouse gas emissions. By 2030, the company aims to reduce absolute Scope 1 and 2 emissions by 55% from a 2019 baseline. Additionally, they plan to cut Scope 3 emissions by 30% within the same timeframe. Long-term, Sanofi is committed to reaching net-zero emissions across all scopes by 2045, with a target to reduce total emissions by 90% from the 2019 baseline. To support these goals, Sanofi is increasing its sourcing of renewable electricity from 11% in 2019 to 80% by 2025, ultimately aiming for 100% by 2030. These initiatives align with industry standards for climate action and demonstrate Sanofi's dedication to sustainability in the pharmaceutical sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 536,712,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 689,058,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sanofi is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
